Kala Pharmaceuticals, Inc. (KALA) shares are up more than 34 percent on Friday morning trade, continuing a rally since December 27 after the company's INDA for KPI-012 for the treatment of persistent corneal epithelial defect or PCED. There have been no other corporate announcements today to influence the stock movement.
The shares are currently at $31.00, up 23.79 percent from the previous close of $24.84 on a volume of 3,494,754.
For comments and feedback contact: editorial@rttnews.com
Business News